Page last updated: 2024-08-25

isoalantolactone and imatinib mesylate

isoalantolactone has been researched along with imatinib mesylate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, C; Gao, FH; Guo, JH; Liu, SL; Liu, Z; Yin, SS; Zhang, C; Zhang, QW	1

Other Studies

1 other study(ies) available for isoalantolactone and imatinib mesylate

Article	Year
Isoalantolactone mediates the degradation of BCR-ABL protein in imatinib-resistant CML cells by down-regulating survivin. Cell cycle (Georgetown, Tex.), 2023, Volume: 22, Issue:12 Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; RNA, Messenger; Survivin; Ubiquitins	2023

Article

Year

Isoalantolactone mediates the degradation of BCR-ABL protein in imatinib-resistant CML cells by down-regulating survivin.

Cell cycle (Georgetown, Tex.), 2023, Volume: 22, Issue:12

Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; RNA, Messenger; Survivin; Ubiquitins

2023